These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6175560)

  • 1. A "spontaneous" cold-reactive IgM antibody with anti HLA-B8 specificity in a patient with multiple sclerosis.
    Lenhard V; Diehm H; Römer W; Rauterberg EW; Kownatzki E; Roelcke D
    Immunobiology; 1982 Feb; 160(5):382-91. PubMed ID: 6175560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A "natural" anti-HLA-A2 antibody reacting with homozygous cells.
    Lepage V; Degos L; Dausset J
    Tissue Antigens; 1976 Aug; 8(2):139-42. PubMed ID: 968899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
    Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
    Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attempts at a demonstration of cross reactivity between the HLA- antigens A2 and B12 or A1 and B8].
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):463-8. PubMed ID: 2414177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.
    Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ
    Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition by a murine monoclonal antibody of a unique epitope specific for the human alloantigen HLA-B8.
    Antonelli P; Nisperos B; Braun M; Hansen JA
    Hum Immunol; 1984 Sep; 11(1):11-8. PubMed ID: 6207153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
    de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the antibody-dependent lymphocytotoxicity test as a function of the nature of the antibodies].
    Levy S; Tongio MM; Mayer S
    Pathol Biol (Paris); 1977 Mar; 25(3):175-7. PubMed ID: 323786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural HLA antibodies.
    Tongio MM; Falkenrodt A; Mitsuishi Y; Urlacher A; Bergerat JP; North ML; Mayer S
    Tissue Antigens; 1985 Nov; 26(5):271-85. PubMed ID: 3879021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.
    McAdam S; Klenerman P; Tussey L; Rowland-Jones S; Lalloo D; Phillips R; Edwards A; Giangrande P; Brown AL; Gotch F
    J Immunol; 1995 Sep; 155(5):2729-36. PubMed ID: 7544382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM anti-idiotypes that block anti-HLA antibodies: naturally occurring or immune antibodies?
    Urlacher A; Tongio MM; Pasquali JL
    Clin Exp Immunol; 1991 Jan; 83(1):116-20. PubMed ID: 1703054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HLA-D-linked low response to polyclonal B-cell activation in multiple sclerosis.
    Paty DW; Cousin HK; Stiller CR; Dossetor JB
    Transplant Proc; 1978 Dec; 10(4):973-5. PubMed ID: 366836
    [No Abstract]   [Full Text] [Related]  

  • 20. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.